BOT short interest (ASX:BOT · BOTANIX PHARMACEUTICALS LTD)
BOTANIX PHARMACEUTICALS LTD (ASX:BOT) short interest is 0.48% as of 1 May 2026. It is down 0.93 percentage points over the past 30 days, it has ranged between 0.22% and 5.23% over the past year.
Short interest over time
Line: net short interest (T+4, ASIC). Bars: ASX gross short-sales activity (T+1), shown as that day's gross short sales as a percent of issued capital rather than a direct read on current open short interest.
Figures are based on ASIC short position reports and reflect a T+4 delay. See About for sourcing and methodology.
Analysis
Short interest trend
The 30-day trend is down but the last week has ticked back up, which can signal fresh shorting after a period of covering.
52-week context
Positioning sits in the bottom 20% of its 52-week range, which is historically subdued for this name.
Peer comparison
BOTANIX PHARMACEUTICALS LTD is less shorted than the peer group median (8.84%), by 8.36 percentage points across 5 comparable tickers.
ASIC T+4 vs ASX T+1
ASIC short interest and the ASX T+1 gross short series should not be compared directly (T+1 gross figure from 4 May 2026). ASIC reports outstanding short positions as a percent of shares on issue, while the ASX file reports that day’s gross short sales as a percent of issued capital. Both are normalised percentages, but one is an open-position stock measure and the other is a same-day flow measure.
How to read this
ASIC short position reports land four business days after trade (T+4). They are the most complete view of outstanding short positioning, but they lag. ASX publishes a T+1 gross short-sales series that describes short-selling activity for that trading session as a percent of issued capital, not the stock of open short positions. The two feeds answer different questions, so they should be read alongside each other rather than interpreted as the same metric.